Cardiogenic Shock Clinical Trials Cardiogenic Shock RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
Conditions:   Acute Myocardial Infarction;   Cardiogenic Shock Interventions:   Drug: Tocilizumab;   Drug: Dobutamine;   Drug: NaCl 0.9% Sponsors:   Rigshospitalet, Denmark;   Novo Nordisk A/S;   Simon Spies Fonden;   Helge Peetz og Verner Peetz og hustru Vilma Peetz Legat Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2022 Category: Research Source Type: clinical trials

Outcomes in CArdiogenic SHock Patients Treated by MEchanical Circulatory suppoRt devicE : Impact of Shock Team
Conditions:   Cardiogenic Shock;   Short Term Mechanical Circulatory Support;   Shock Team Intervention:   Other: standard of care Sponsor:   University Hospital, Bordeaux Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2022 Category: Research Source Type: clinical trials